Resultados de la búsqueda 221-230 of 12692 for supplement interactions
Abemaciclib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Olaparib is an inhibitor of PARP, an enzyme that helps ...
The purpose of this study is to assess the presence of various molecular markers in histiocytic disorders. In addition to this, to review clinical records of ...
Olaparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as temozolomide, work in ...
La sábila, o áloe vera, es una planta que produce dos sustancias utilizadas en productos para el cuidado de la salud: un gel transparente y un látex ...
Necesitas perder peso? Olvídate de las dietas relámpago. Adopta hábitos de alimentación saludable y ejercicio. Es la forma inteligente de perder peso y no ...
15, 2017. Aug. 10, 2023. Original article: https://www.mayoclinic.org/es/drugs-supplements-honey/art-20363819 . Mayo Clinic Footer. Legal Conditions and ...
This study is being conducted to determine gene and protein expression profiles (i.e. which genes and proteins are turned off and on) of those with a ...
Imperforate Anus, also known as anal atresia, is a rare birth defect. Unable to pass stool through the gastrointestinal tract, this condition can result in ...
The purpose of this study is to evaluate olaparib and temozolomide in treating patients with uterine leiomyosarcoma (LMS) that has spread to other places of ...
The purpose of this study is to determine whether meeting the physical activity guidelines for cardiometabolic health is associated with positive ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?